Clinical Trial Update: Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating valproate as an adjunctive treatment for Toxoplasma gondii infection in early course schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Toxoplasmosis

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: University of Pittsburgh | Conditions: Toxoplasmosis, Schizophrenia | Phase 4 | Status: COMPLETED